Risk-Based Approach Supports Migration Of Legacy Methods For Eurofins BPT Toronto

Eurofins BioPharma Product Testing (BPT) division delivers a comprehensive scope of GMP testing services for some of the world's largest pharmaceutical, biopharmaceutical, and medical device companies. Eurofins BPT Toronto provides chemical, microbial, stability, and sterility testing on a vast array of products ranging from raw materials to finished products. The company focuses on delivering accurate, reliable, and timely results to its clients, and is proud of its strong emphasis on customer service.

They recently evaluated the Waters Arc HPLC system's ability to replicate existing liquid chromatography (LC) methods, without compromising data quality or requiring changes to original method. They saw an opportunity to apply a modern, risk-based approach to method migration and to understand the impact of introducing state-of-the-art technology for their legacy methods.

The goal of the project was to ensure that the lab's potential switchover from it's legacy systems to the Waters systems would be seamless, while ensuring data equivalency and regulatory compliance.